Regression of BRAF(V600E) mutant adult glioblastoma after primary combined BRAF-MEK inhibitor targeted therapy: a report of two cases

por Woo, Peter Y.M., Lam, Tai-Chung, Pu, Jenny K.S., Li, Lai-Fung, Leung, Roland C.Y., Ho, Jason M.K., Zhung, James T.F., Wong, Belinda, Chan, Timonthy S.K., Loong, Herbert H.F., Ng, Ho-Keung
Publicado 2019